QbD Group

QbD Group supports pharmaceutical and biotech companies in developing, manufacturing and bringing innovative therapies to patients worldwide. As a strategic life sciences partner, we provide integrated expertise across the entire pharmaceutical product lifecycle, from early research and development to regulatory approval, manufacturing readiness and post-market support.

Our multidisciplinary teams combine regulatory affairs, CMC development, quality and compliance, pharmacovigilance and operational execution to help organisations navigate complex regulatory environments and accelerate market access.

QbD works with emerging biotech companies, mid-size pharmaceutical firms, and global manufacturers to transform scientific innovation into compliant, scalable and market-ready medicines, delivering both strategic guidance and hands-on operational support through our integrated solutions.

Acting as an end-to-end partner across the pharma journey, from early development to post-market lifecycle management, we help organisations bring therapies to market efficiently, compliantly and with confidence.

USP bullets

• End-to-end lifecycle support for pharmaceutical and biotech companies, from early development to post-market lifecycle management.
• Integrated expertise across regulatory affairs, CMC development, quality systems, manufacturing and pharmacovigilance.
• Specialised support for emerging biotech companies building regulatory, quality and operational foundations.
• Manufacturing, GMP and quality compliance expertise, enabling inspection readiness and sustainable regulatory compliance.
• Practical delivery model combining strategic consulting with hands-on operational implementation.
• Flexible engagement models supporting biotech startups, scale-ups and global pharmaceutical organisations.

Top healthcare consulting services to highlight

Emerging biotech

Supporting biotech startups and emerging pharmaceutical innovators as they move from early research to structured development and market readiness. QbD provides integrated support across regulatory strategy, quality systems, CMC development and clinical readiness. Helping companies build the operational and regulatory foundations needed to successfully advance their therapies.

Manufacturing, quality and compliance

Comprehensive support for pharmaceutical manufacturing environments and GMP compliance. QbD helps companies establish robust quality systems, prepare for regulatory inspections, manage manufacturing scale-up and ensure sustainable compliance throughout the product lifecycle.

Lifecycle management

Strategic and operational support to manage pharmaceutical products throughout their entire lifecycle, from regulatory approval to post-market optimisation and portfolio management.

QbD helps companies maintain compliance, implement regulatory variations, manage product changes and optimise lifecycle strategies to maximise product value while ensuring continued regulatory alignment and patient safety.

European market entry

Supporting pharmaceutical and biotech companies in successfully entering and expanding within the European market. QbD provides structured guidance across regulatory strategy, EU regulatory procedures and compliance requirements, helping organisations navigate the complexity of the European regulatory landscape.

From early regulatory pathway assessment and market-entry strategy to dossier preparation, regulatory interactions and post-approval support, our experts help companies establish a clear, compliant and efficient route to European market access.